NSEDCP
NJ State Employees Deferred Compensation Plan’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $263K | Hold |
500
| – | – | 0.03% | 366 |
|
|
2025
Q1 | $317K | Hold |
500
| – | – | 0.04% | 349 |
|
|
2024
Q4 | $356K | Hold |
500
| – | – | 0.04% | 344 |
|
|
2024
Q3 | $526K | Hold |
500
| – | – | 0.06% | 280 |
|
|
2024
Q2 | $526K | Hold |
500
| – | – | 0.07% | 270 |
|
|
2024
Q1 | $481K | Hold |
500
| – | – | 0.06% | 298 |
|
|
2023
Q4 | $439K | Hold |
500
| – | – | 0.06% | 309 |
|
|
2023
Q3 | $411K | Hold |
500
| – | – | 0.06% | 295 |
|
|
2023
Q2 | $359K | Hold |
500
| – | – | 0.05% | 336 |
|
|
2023
Q1 | $411K | Hold |
500
| – | – | 0.06% | 321 |
|
|
2022
Q4 | $361K | Hold |
500
| – | – | 0.06% | 327 |
|
|
2022
Q3 | $344K | Hold |
500
| – | – | 0.06% | 330 |
|
|
2022
Q2 | $296K | Hold |
500
| – | – | 0.05% | 357 |
|
|
2022
Q1 | $349K | Hold |
500
| – | – | 0.05% | 367 |
|
|
2021
Q4 | $316K | Hold |
500
| – | – | 0.04% | 389 |
|
|
2021
Q3 | $303K | Hold |
500
| – | – | 0.04% | 393 |
|
|
2021
Q2 | $279K | Hold |
500
| – | – | 0.04% | 433 |
|
|
2021
Q1 | $237K | Hold |
500
| – | – | 0.03% | 456 |
|
|
2020
Q4 | $242K | Hold |
500
| – | – | 0.04% | 421 |
|
|
2020
Q3 | $280K | Hold |
500
| – | – | 0.05% | 341 |
|
|
2020
Q2 | $312K | Hold |
500
| – | – | 0.06% | 316 |
|
|
2020
Q1 | $244K | Buy |
+500
| New | +$244K | 0.06% | 334 |
|